Afinitor Helps Breast Tx in Older Patients MedPage Today SAN FRANCISCO -- Older patients with advanced, relapsed, estrogen receptor-positive breast cancer had significant improvement in progression-free survival with no increased toxicity when the mTOR inhibitor everolimus (Afinitor) was added to exemestane ... |
